Dr. Praveen Roayapalley, B.Sc, M.Sc, PhD

Postdoctoral Scholars, Faculty of Engineering - Chemical and Materials Engineering Dept

Pronouns: HE

Contact Publications

Contact

Postdoctoral Scholars, Faculty of Engineering - Chemical and Materials Engineering Dept

Email: roayapal@ualberta.ca

Featured Publications

Does Ortho-Substitution Enhance Cytotoxic Potencies in a Series of 3,5-Bis(benzylidene)-4-piperidones?

Subhas S. Karki, Umashankar Das, Jan Balzarini, Erik De Clercq, Hiroshi Sakagami, Yoshihiro Uesawa, Praveen K. Roayapalley, Jonathan R. Dimmock

Medicines. 2024 October; 10.3390/medicines11080019

Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships

Swagatika Das, Praveen Kumar Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K. J. Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, Jonathan R. Dimmock

Medicines. 2024 January; 10.3390/medicines11010003

Anticonvulsant Properties of 1-Diethylamino-3-phenylprop-2-en-1-one

Swagatika Das, Praveen K. Roayapalley, Sarvesh C. Vashishtha, Umashankar Das, Jonathan R. Dimmock

Medicines. 2023 September; 10.3390/medicines10090054

Are the cytotoxic properties of conjugated unsaturated ketones inactivated by thiols?

Die Pharmazie. 2023 January; 10.1691/PH.2023.3542

1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)- 4-Piperidone Hydrochloride and Related Compounds: Potent Cytotoxins Demonstrate Greater Toxicity to Neoplasms than Non- Malignant Cells

Praveen K. Roayapalley, Jonathan R. Dimmock, Hiroshi Sakagami, Noriyki Okudaira, Rajendra K. Sharma, Umashankar Das

Medicinal Chemistry. 2022 November; 10.2174/1573406418666220322154110

Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity

Aruna Chhikara, Praveen K. Roayapalley, Hiroshi Sakagami, Shigeru Amano, Keitaro Satoh, Yoshihiro Uesawa, Umashankar Das, Swagatika Das, Edgar A. Borrego, Cristina D. Guerena, Clare R. Hernandez, Renato J. Aguilera, Jonathan R. Dimmock

Molecules. 2022 October; 10.3390/molecules27196718

Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells

Mohammad Hossain, Praveen K. Roayapalley, Hiroshi Sakagami, Keitaro Satoh, Kenjiro Bandow, Umashankar Das, Jonathan R. Dimmock

Medicines. 2022 June; 10.3390/medicines9060035

Cytotoxic benzylidene hydrazides of terephthalic acid and related compounds.

Die Pharmazie. 2022 April; 10.1691/ph.2022.11072

Cytotoxic Tumour-Selective 1,5-Diaryl-3-Oxo-1,4-Pentadienes Mounted on a Piperidine Ring

Praveen K. Roayapalley, Hiroshi Sakagami, Keitaro Satoh, Shigeru Amano, Kenjiro Bandow, Renato J. Aguilera, Karla G. Cano Hernandez, Austre Y. Schiaffino Bustamante, Stephen G. Dimmock, Rajendra K. Sharma, Umashankar Das, Jonathan R. Dimmock

Medicines. 2021 December; 10.3390/medicines8120078

Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts

Praveen Kumar Roayapalley, Jonathan R. Dimmock, Lisett Contreras, Karol S. Balderrama, Renato J. Aguilera, Hiroshi Sakagami, Shigeru Amano, Rajendra K. Sharma, Umashankar Das

Molecules. 2021 November; 10.3390/molecules26237132

Design, Syntheses, and Bioevaluations of Some Novel N2-Acryloylbenzohydrazides as Chemostimulants and Cytotoxic Agents

Medicines. 2021 June; 10.3390/medicines8060027

6-Benzylidene-2-[4-(pyridin-3-ylcarboxy)benzylidene]cyclohexanones: A novel cluster of tumour-selective cytotoxins

Bioorganic and Medicinal Chemistry Letters. 2017 January; 10.1016/j.bmcl.2017.02.016

Synthesis of O-propylated canola oil derivatives using Al-SBA-15 (10) catalyst and study on their application as fuel additive

Catalysis Today. 2017 January; 10.1016/J.CATTOD.2017.04.041

Niacin esters of chalcones with tumor-selective properties

Journal of Enzyme Inhibition and Medicinal Chemistry. 2016 January; 10.3109/14756366.2016.1144595

Antinociceptive activity of alpha 4 beta 2*neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain

European Journal of Pharmacology. 2011 January; 10.1016/J.EJPHAR.2011.06.032

P3‐332: SUVN‐91052: A potent and selective 5‐HT 4 agonist for the treatment of Alzheimer's disease

Alzheimer's & Dementia. 2010 July; 10.1016/j.jalz.2010.05.1833

View additional publications